Does Kentucky Medicaid cover residential rehab?
Yes. Kentucky's 1115 demonstration waiver lifts the historic IMD exclusion for SUD — meaning Medicaid pays for residential rehab at full-size licensed facilities, not only at small (≤16 bed) programs.
Golden Grove Recovery is closed and preparing to reopen in Louisville, KY. Coverage information on this page describes Kentucky Medicaid substance use treatment in general — your individual coverage depends on your specific plan, plan year, and medical-necessity determination. Call admissions to talk through your situation.
Kentucky Medicaid plans typically cover residential.
Kentucky Medicaid plans typically cover residential substance use treatment based on medical-necessity determination using the American Society of Addiction Medicine (ASAM) (American Society of Addiction Medicine) criteria, and Golden Grove will also work with most major insurance plans, with self-pay as an option. Prior authorization with concurrent review is typical. Coverage check happens on the call.
Insurance disclaimer: Golden Grove Recovery is in pre-opening setup. The information on this page helps you understand Kentucky Medicaid coverage for substance use treatment. Contact admissions to discuss your individual situation and treatment options.
The standard of care for severe SUD.
Residential treatment is 24/7 supervised care in a structured, sober environment. Residential programming addresses the medical, psychological, and social dimensions of substance use disorder through individual therapy, group therapy, psychoeducation, family involvement, and medication management — including medication-assisted treatment (MAT) where indicated. It is the standard of care for patients who need the stability and protection of a structured environment after detox.
Typical duration: Determined by medical necessity · Setting: 24/7 nursing support with structured programming
How the waiver makes residential accessible.
Kentucky's Medicaid 1115 demonstration waiver allows Medicaid to pay for residential substance use disorder (SUD) treatment in IMD-sized (institution for mental disease) facilities, making residential care accessible to Medicaid members statewide.
In practical terms: Kentucky's waiver is why Medicaid can pay for residential treatment at full-size licensed centers in Kentucky at all. Whether it pays for a given stay depends on the plan and medical necessity — something that is not possible in many states.
What comes before and after residential.
Common questions about residential coverage.
- Does Kentucky Medicaid cover residential rehab?
- Yes. Kentucky Medicaid plans typically cover residential SUD treatment at ASAM 3.1, 3.3, and 3.5 based on medical-necessity determination using ASAM criteria.
- What is the IMD exclusion and does it affect me?
- The Institution for Mental Disease (IMD) exclusion historically blocked Medicaid from paying for residential SUD treatment in facilities larger than 16 beds. Kentucky's 1115 demonstration waiver lifts this restriction.
- How long will Medicaid pay for residential treatment?
- Coverage continues as long as residential level of care remains medically necessary, determined by ASAM criteria and concurrent clinical review. Duration is individualized — call admissions to talk through what's likely for your situation.
- Does residential coverage include MAT?
- Yes. Kentucky Medicaid covers medication-assisted treatment alongside residential care when medically necessary. Golden Grove's MAT will be Suboxone, Subutex and Vivitrol, delivered inside residential care; methadone is a Kentucky Medicaid benefit provided through separate licensed opioid treatment programs, not at Golden Grove.
Talk to admissions about residential.
Admissions answers 24/7. Call admissions with your plan name — coverage check happens on the call.